(Bio)Artificial Liver

This is a preliminary program for the session. 

Chairs

Announced soon

The programme

This is a preliminary program based on submitted abstracts from experts in the field. The scientific committee of ESAO 2025 has then brought them together in the sessions below. The speakers listed below must confirm their participation by purchasing a ticket before the early bird deadline (April 25).

Time

Presentation

1 min

Welcome and introduction

18 min

Purified Granulocytes In Extracorporeal Cell Therapy: Unique Dosing Regimens Challenging Conventional Blood Purification Techniques

Gerd Klinkmann, Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University of Rostock, Germany; Department of Extracorporeal Therapy Systems, Fraunhofer Institute for Cell Therapy and Immunology, Germany; International Renal Research Institute of Vicenza (IRRIV), Italy

18 min

Normothermic Machine Perfusion Of Explanted Human Metabolic Livers: A Proof Of Concept For Studying Inborn Errors Of Metabolism

Riccardo Cirelli, Clinical Hepatogastroenterology and Transplantation Research Unit, Bambino Gesù Pediatric Hospital IRCCS (OPBG), Italy; HPB Surgery, Liver and Kidney Transplantation division, OPBG, Italy

18 min

The Number Of Apheresis Procedures To Treat Immune-Mediated Neurological Diseases Is On The Rise

Bernd Stegmayr, Department of Public Health and Clinical Medicine, Unit Medicine, Umea University, Umea, Sweden

18 min

Aggravated Sepsis, Acute Kidney Injury And Microbiological Resistance In Four Years Pre-Post Covid Outcome Study

Aleksandra Canevska-Taneska, University Clinic of Nephrology; Medical Faculty, Ss Cyril and Methodius University, North Macedonia, Republic of

18 min

Finding The Optimal Sterilization Method For Human Decellularized Livers: Assessing Microbiome, Matrix Proteins, And Biocompatibility

Elena van Hengel, Erasmus MC Transplant Institute


Closing words